title: A presentation of Poncet's disease identified following immunosuppressive steroid therapy.
authors.forename: V
authors.initials: V
authors.lastname: Kasivisvanathan
authors.forename: D W
authors.initials: DW
authors.lastname: Connell
authors.forename: P L
authors.initials: PL
authors.lastname: Molyneaux
authors.forename: A
authors.initials: A
authors.lastname: Singanayagam
authors.forename: P M
authors.initials: PM
authors.lastname: George
authors.forename: C
authors.initials: C
authors.lastname: Tench
authors.forename: O M
authors.initials: OM
authors.lastname: Kon
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D003692:Delayed-Action Preparations; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D008775:Methylprednisolone / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D000077555:Methylprednisolone Acetate; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification*; D014394:Tuberculosis, Osteoarticular / Q000175:diagnosis* / Q000209:etiology / Q000503:physiopathology
chemical_list: D000893:Anti-Inflammatory Agents; D003692:Delayed-Action Preparations; D007166:Immunosuppressive Agents; D000077555:Methylprednisolone Acetate; D008775:Methylprednisolone